SCHEMBL30730372

SCHEMBL30730372

COc1ccc(C(F)(F)C(=O)NN)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.56
CA2 P00918 4/20 0.56
PDK1 Q15118 1/20 0.50
PDK2 Q15119 1/20 0.50
PDK3 Q15120 1/20 0.50
PDK4 Q16654 1/20 0.50
ALDH1A1 P00352 3/20 0.49
MAPT P10636 3/20 0.49
HTT P42858 1/20 0.49
LMNA P02545 1/20 0.45
ALOX15 P16050 1/20 0.45
APEX1 P27695 1/20 0.45
MAPK1 P28482 1/20 0.45
RECQL P46063 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KDM4E B2RXH2 1/20 0.45
PLK1 P53350 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30087732 0.80 CA1 (0.52) CA1CA2ALDH1A1MAPTLMNA
SCHEMBL20325773 0.79 MAPT (0.49) CA1CA2PDK1PDK2PDK3
SCHEMBL17420611 0.78 CA1 (0.50) CA1CA2ALDH1A1MAPTLMNA
SCHEMBL5740555 0.78 KCNN4 (0.48) ALDH1A1MAPTHTTMAPK1KDM4E
SCHEMBL30730384 0.77 ALDH1A1 (0.52) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL28637684 0.77 MAPT (0.46) CA1CA2PDK1PDK2PDK3
SCHEMBL21501142 0.77 CA1 (0.48) CA1CA2ALDH1A1MAPTLMNA
SCHEMBL16147948 0.75 CES2 (0.53) CA1CA2ALDH1A1MAPTLMNA
SCHEMBL18262545 0.74 CA1 (0.50) CA1CA2PDK1PDK2PDK3
SCHEMBL18262542 0.74 CA1 (0.50) CA1CA2PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562015-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 EP disclosed
WO-2024026481-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed